tiprankstipranks
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market
AARTIDRUGS
Aarti Drugs Limited
RESEARCH TOOLSreports
Want to see IN:AARTIDRUGS full AI Analyst Report?

Aarti Drugs Limited (AARTIDRUGS) Financial Statements

3 Followers

Aarti Drugs Limited Financial Overview

Aarti Drugs Limited's market cap is currently ₹35.55B. The company's EPS TTM is ₹21.8; its P/E ratio is 14.97; and it has a dividend yield of 0.24%. Aarti Drugs Limited is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 25.65B₹ 23.87B₹ 25.29B₹ 27.16B₹ 24.89B
Gross Profit₹ 7.50B₹ 8.45B₹ 8.51B₹ 3.69B₹ 3.89B
Operating Income₹ 2.42B₹ 7.33B₹ 2.69B₹ 2.65B₹ 2.88B
EBITDA₹ 3.09B₹ 2.87B₹ 3.25B₹ 3.12B₹ 3.44B
Net Income₹ 1.95B₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B
Balance Sheet
Cash & Short-Term Investments₹ 88.10M₹ 226.10M₹ 89.28M₹ 211.70M₹ 343.81M
Total Assets₹ 28.15B₹ 25.75B₹ 24.32B₹ 24.21B₹ 22.08B
Total Debt₹ 5.77B₹ 6.15B₹ 5.64B₹ 6.09B₹ 5.43B
Net Debt₹ 5.68B₹ 6.08B₹ 5.58B₹ 6.00B₹ 5.21B
Total Liabilities₹ 12.66B₹ 12.05B₹ 11.50B₹ 12.29B₹ 11.72B
Stockholders' Equity₹ 15.49B₹ 13.69B₹ 12.82B₹ 11.92B₹ 10.36B
Cash Flow
Free Cash Flow₹ 490.90M₹ 674.20M₹ 1.33B₹ -304.70M₹ -823.39M
Operating Cash Flow₹ 2.22B₹ 2.45B₹ 3.59B₹ 1.34B₹ 696.36M
Investing Cash Flow₹ -1.75B₹ -1.65B₹ -2.24B₹ -1.64B₹ -1.49B
Financing Cash Flow₹ -451.40M₹ -821.20M₹ -1.36B₹ 165.40M₹ 920.25M
Currency in INR

Aarti Drugs Limited Earnings and Revenue History

Income Statement >

Aarti Drugs Limited Debt to Assets

Balance Sheet >

Aarti Drugs Limited Cash Flow

Cash Flow >

Aarti Drugs Limited Forecast EPS vs Actual EPS

Earnings >